From Name

From Email

To Name

To Email

Message

HPV test misses twice as many women who develop cervical cancer as cotesting, Quest Diagnostics Health Trends^â„¢ study finds

from Quest Diagnostics

HPV test misses twice as many women who develop cervical cancer as cotesting, Quest Diagnostics Health Trendsâ„¢ study finds Quest Diagnostics A Health Trendsâ„¢ study from researchers at Quest Diagnostics and the University of Pittsburgh Medical Center (UPMC) provides new evidence that the HPV screening test is significantly less likely to detect cervical cancer and precancer than cotesting, a method which combines HPV and Pap (Papanicolaou test by liquid based cytology) testing using the same specimen. READ MORE

more